Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome

Published:2016-07-13 Issue:2 Volume:179 Page:339-341
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mason Christopher¹,Savona Steven¹,Rini Josephine N.²³,Castillo Jorge J.⁴,Xu Lian⁴,Hunter Zachary R.⁴,Treon Steven P.⁴,Allen Steven L.¹

Affiliation:

1. Division of Hematology; Northwell Health Cancer Institute; Hofstra Northwell School of Medicine; Lake Success NY USA

2. Hofstra Northwell School of Medicine; Lake Success NY USA

3. Department of Radiology; Hofstra Northwell School of Medicine; Lake Success NY USA

4. Bing Center for Waldenstrom's Macroglobulinemia; Dana Farber Cancer Institute; Harvard Medical School; Boston MA USA

Funder

Peter S. Bing

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14218/fullpdf

Reference10 articles.

1. Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse;Bernard;Blood,2015

2. Two cases of hyperglobulinaemia with affection of the central nervous system on a toxi-infectious basis;Bing;Acta Medica Scandinavica,1936

3. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome;Cabannes-Hamy;American Journal of Hematology,2016

4. Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study;Castillo;British Journal of Haematology,2016

5. Phase I study of dose-adjusted Teddi-R with ibrutinib in untreated and relapsed/refractory primary CNS lymphoma;Dunleavy;Blood,2015

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ibrutinib as treatment for Bing–Neel syndrome reclassified as glioblastoma: a case report;Journal of Medical Case Reports;2024-09-11

2. Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes;Frontiers in Dementia;2024-08-16

3. How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia;Blood;2024-04-25

4. Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia;Current Hematologic Malignancy Reports;2024-03-27

5. Waldenstrom Macroglobulinemia;Comprehensive Hematology and Stem Cell Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3